GetTopicDetailResponse(id=f4b511289e51, topicName=AASLD2023, introduction=AASLD2023, content=慢乙肝 聚乙二醇干擾素α AASLD2023, image=null, comments=0, allHits=1145, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Fri Mar 29 13:12:18 CST 2024, time=2024-03-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=488917, tagList=[TagDto(tagId=488917, tagName=AASLD2023)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2198679, encodeId=fab521986e94a, content=<a href='/topic/show?id=9d3d812280b' target=_blank style='color:#2F92EE;'>#肝損傷#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=f4b511289e51' target=_blank style='color:#2F92EE;'>#AASLD2023#</a> <a href='/topic/show?id=b1191134087c' target=_blank style='color:#2F92EE;'>#qAnti-HBc#</a>, objectTitle=【AASLD2023速遞】再次證實(shí)：qAnti-HBc可作為ALT正常慢乙肝患者嚴(yán)重肝損傷的預(yù)測(cè)指標(biāo), objectType=article, longId=820449, objectId=fc55820449de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=fc55820449de, replyNumber=0, likeNumber=153, createdTime=2024-04-15, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=fc55820449de, moduleTitle=【AASLD2023速遞】再次證實(shí)：qAnti-HBc可作為ALT正常慢乙肝患者嚴(yán)重肝損傷的預(yù)測(cè)指標(biāo), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fc55820449de)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196323, encodeId=6d7f219632337, content=<a href='/topic/show?id=f4b511289e51' target=_blank style='color:#2F92EE;'>#AASLD2023#</a> <a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a> <a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#發(fā)病率#</a>, objectTitle=【AASLD2023速遞】香港研究：預(yù)計(jì)2030年底香港乙肝發(fā)病率將下降36%, objectType=article, longId=818456, objectId=81ad81845608, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/black-surgeon-giving-instruction-to-medical-team-TMPFGNZ.jpg, objectUrl=/article/show_article.do?id=81ad81845608, replyNumber=0, likeNumber=102, createdTime=2024-03-31, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=81ad81845608, moduleTitle=【AASLD2023速遞】香港研究：預(yù)計(jì)2030年底香港乙肝發(fā)病率將下降36%, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=81ad81845608)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196347, encodeId=2e01219634e03, content=<a href='/topic/show?id=f4b511289e51' target=_blank style='color:#2F92EE;'>#AASLD2023#</a> <a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治療#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=769099e24d7' target=_blank style='color:#2F92EE;'>#非酒精性脂肪性肝病#</a>, objectTitle=【AASLD2023速遞】在抗病毒治療應(yīng)答不佳的慢乙肝患者中，超40%的患者合并NAFLD, objectType=article, longId=818352, objectId=990e8183528c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing.jpg, objectUrl=/article/show_article.do?id=990e8183528c, replyNumber=0, likeNumber=142, createdTime=2024-03-31, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=990e8183528c, moduleTitle=【AASLD2023速遞】在抗病毒治療應(yīng)答不佳的慢乙肝患者中，超40%的患者合并NAFLD, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=990e8183528c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196046, encodeId=ab2b219604661, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干擾素α#</a> <a href='/topic/show?id=f4b511289e51' target=_blank style='color:#2F92EE;'>#AASLD2023#</a>, objectTitle=【AASLD2023速遞】治療應(yīng)答探索：差異表達(dá)基因或會(huì)影響慢乙肝患者對(duì)聚乙二醇干擾素α的應(yīng)答, objectType=article, longId=818249, objectId=bc1d818249ff, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/filling-medical-history-XZB9RVX.jpg, objectUrl=/article/show_article.do?id=bc1d818249ff, replyNumber=0, likeNumber=107, createdTime=2024-03-29, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=bc1d818249ff, moduleTitle=【AASLD2023速遞】治療應(yīng)答探索：差異表達(dá)基因或會(huì)影響慢乙肝患者對(duì)聚乙二醇干擾素α的應(yīng)答, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bc1d818249ff)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-03-29發(fā)表于陜西省
